The nuclear coactivator Amplified In Breast Cancer 1 maintains tumor initiating cells during development of Ductal Carcinoma In Situ

The key molecular events required for the formation of Ductal Carcinoma in Situ (DCIS) and its progression to invasive breast carcinoma have not been defined. Here we show that the nuclear receptor coactivator Amplified In Breast cancer 1 (AIB1) is expressed at low levels in normal breast but is hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Ory, V, Tassi, E, Cavalli, LR, Sharif, GM, Saenz, F, Baker, T, Schmidt, MO, Mueller, SC, Furth, PA, Wellstein, A, Riegel, AT
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943533/
https://www.ncbi.nlm.nih.gov/pubmed/23851504
http://dx.doi.org/10.1038/onc.2013.263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943533/
https://www.ncbi.nlm.nih.gov/pubmed/23851504
http://dx.doi.org/10.1038/onc.2013.263

Ejemplares similares